NL6814256A - - Google Patents

Info

Publication number
NL6814256A
NL6814256A NL6814256A NL6814256A NL6814256A NL 6814256 A NL6814256 A NL 6814256A NL 6814256 A NL6814256 A NL 6814256A NL 6814256 A NL6814256 A NL 6814256A NL 6814256 A NL6814256 A NL 6814256A
Authority
NL
Netherlands
Application number
NL6814256A
Other versions
NL157900B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6814256A publication Critical patent/NL6814256A/xx
Publication of NL157900B publication Critical patent/NL157900B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Fuel Combustion (AREA)
NL6814256.A 1967-10-04 1968-10-04 Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking op basis van een functioneel derivaat van 2-methyl-3-carboxylchinoxaline-1,4-dioxyde, aldus gevormde preparaten, alsmede een werkwijze ter bereiding van de actieve verbindingen. NL157900B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1670937A DE1670937C3 (de) 1967-10-04 1967-10-04 2-Halogenmethyl-3-carbonsäureamidochinoxalin-di-N-oxide-( 1.4)

Publications (2)

Publication Number Publication Date
NL6814256A true NL6814256A (da) 1969-04-09
NL157900B NL157900B (nl) 1978-09-15

Family

ID=7106504

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6814256.A NL157900B (nl) 1967-10-04 1968-10-04 Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking op basis van een functioneel derivaat van 2-methyl-3-carboxylchinoxaline-1,4-dioxyde, aldus gevormde preparaten, alsmede een werkwijze ter bereiding van de actieve verbindingen.

Country Status (14)

Country Link
US (2) US3557109A (da)
AT (1) AT284128B (da)
CH (1) CH512499A (da)
DE (1) DE1670937C3 (da)
DK (1) DK118288B (da)
ES (1) ES358796A1 (da)
FI (1) FI49718C (da)
FR (2) FR1597551A (da)
GB (1) GB1188249A (da)
IL (1) IL30706A (da)
NL (1) NL157900B (da)
NO (1) NO122018B (da)
SE (1) SE344329B (da)
YU (1) YU32936B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2059542A1 (da) * 1969-07-22 1971-06-04 Pfizer

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343942A (en) * 1966-11-08 1982-08-10 Research Corporation Quinoxaline derivatives
GB1408675A (en) * 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US3728345A (en) * 1971-03-19 1973-04-17 Pfizer Preparation of quinoxaline-2-carboxamide derivatives
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
US4418063A (en) * 1978-12-19 1983-11-29 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
WO2012096556A1 (es) * 2011-01-11 2012-07-19 Antonio Monge Derivados de quinoxalina selectivos contra trypanosoma cruzi y que no causan efectos mutagénicos

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2059542A1 (da) * 1969-07-22 1971-06-04 Pfizer

Also Published As

Publication number Publication date
DK118288B (da) 1970-08-03
SE344329B (da) 1972-04-10
FI49718C (fi) 1975-09-10
IL30706A0 (en) 1969-02-27
FR8125M (da) 1970-08-03
CH512499A (de) 1971-09-15
US3557109A (en) 1971-01-19
ES358796A1 (es) 1970-05-01
FI49718B (da) 1975-06-02
YU229568A (en) 1975-06-30
US3754087A (en) 1973-08-21
AT284128B (de) 1970-09-10
YU32936B (en) 1975-12-31
FR1597551A (da) 1970-06-29
GB1188249A (en) 1970-04-15
NO122018B (da) 1971-05-10
IL30706A (en) 1972-05-30
NL157900B (nl) 1978-09-15
DE1670937A1 (de) 1971-02-25
DE1670937B2 (de) 1978-12-21
DE1670937C3 (de) 1979-08-30

Similar Documents

Publication Publication Date Title
AU425114B2 (da)
AU416737B2 (da)
AU2277767A (da)
AU342066A (da)
AU2977667A (da)
AU2256867A (da)
AU2116667A (da)
AU610966A (da)
AU1273466A (da)
AU3189468A (da)
AU3151267A (da)
AU2528767A (da)
AU2454867A (da)
BE162295A (da)
AU1677166A (da)
BE704275A (da)
BE697121A (da)
AU1763766A (da)
AU23366A (da)
AU2406369A (da)
BE695001A (da)
BE692493A (da)
BE692779A (da)
BE692198A (da)
AU3054676A (da)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: BAYER